121 related articles for article (PubMed ID: 28534517)
1. Prolonged exposure to extracellular lumican restrains pancreatic adenocarcinoma growth.
Li X; Kang Y; Roife D; Lee Y; Pratt M; Perez MR; Dai B; Koay EJ; Fleming JB
Oncogene; 2017 Sep; 36(38):5432-5438. PubMed ID: 28534517
[TBL] [Abstract][Full Text] [Related]
2. Transforming Growth Factor-β Limits Secretion of Lumican by Activated Stellate Cells within Primary Pancreatic Adenocarcinoma Tumors.
Kang Y; Roife D; Lee Y; Lv H; Suzuki R; Ling J; Rios Perez MV; Li X; Dai B; Pratt M; Truty MJ; Chatterjee D; Wang H; Thomas RM; Wang Y; Koay EJ; Chiao PJ; Katz MH; Fleming JB
Clin Cancer Res; 2016 Oct; 22(19):4934-4946. PubMed ID: 27126993
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenvironment of pancreatic ductal adenocarcinoma.
Li X; Lee Y; Kang Y; Dai B; Perez MR; Pratt M; Koay EJ; Kim M; Brekken RA; Fleming JB
Cell Death Differ; 2019 Jan; 26(2):382-393. PubMed ID: 30283082
[TBL] [Abstract][Full Text] [Related]
4. Extracellular lumican inhibits pancreatic cancer cell growth and is associated with prolonged survival after surgery.
Li X; Truty MA; Kang Y; Chopin-Laly X; Zhang R; Roife D; Chatterjee D; Lin E; Thomas RM; Wang H; Katz MH; Fleming JB
Clin Cancer Res; 2014 Dec; 20(24):6529-40. PubMed ID: 25336691
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor β receptor signaling restrains growth of pancreatic carcinoma cells.
Zhao Z; Xi H; Xu D; Li C
Tumour Biol; 2015 Sep; 36(10):7711-6. PubMed ID: 25934336
[TBL] [Abstract][Full Text] [Related]
6. Extracellular lumican augments cytotoxicity of chemotherapy in pancreatic ductal adenocarcinoma cells via autophagy inhibition.
Li X; Roife D; Kang Y; Dai B; Pratt M; Fleming JB
Oncogene; 2016 Sep; 35(37):4881-90. PubMed ID: 26876211
[TBL] [Abstract][Full Text] [Related]
7. Analysis of protein expression regulated by lumican in PANC‑1 cells using shotgun proteomics.
Yamamoto T; Kudo M; Peng WX; Naito Z
Oncol Rep; 2013 Oct; 30(4):1609-21. PubMed ID: 23846574
[TBL] [Abstract][Full Text] [Related]
8. Secreted 70kDa lumican stimulates growth and inhibits invasion of human pancreatic cancer.
Yamamoto T; Matsuda Y; Kawahara K; Ishiwata T; Naito Z
Cancer Lett; 2012 Jul; 320(1):31-9. PubMed ID: 22266188
[TBL] [Abstract][Full Text] [Related]
9. FoxO1-negative cells are cancer stem-like cells in pancreatic ductal adenocarcinoma.
Song W; Li Q; Wang L; Huang W; Wang L
Sci Rep; 2015 Jun; 5():10081. PubMed ID: 26068418
[TBL] [Abstract][Full Text] [Related]
10. Reprogramming pancreatic stellate cells via p53 activation: A putative target for pancreatic cancer therapy.
Saison-Ridinger M; DelGiorno KE; Zhang T; Kraus A; French R; Jaquish D; Tsui C; Erikson G; Spike BT; Shokhirev MN; Liddle C; Yu RT; Downes M; Evans RM; Saghatelian A; Lowy AM; Wahl GM
PLoS One; 2017; 12(12):e0189051. PubMed ID: 29211796
[TBL] [Abstract][Full Text] [Related]
11. Regulation of GLI Underlies a Role for BET Bromodomains in Pancreatic Cancer Growth and the Tumor Microenvironment.
Huang Y; Nahar S; Nakagawa A; Fernandez-Barrena MG; Mertz JA; Bryant BM; Adams CE; Mino-Kenudson M; Von Alt KN; Chang K; Conery AR; Hatton C; Sims RJ; Fernandez-Zapico ME; Wang X; Lillemoe KD; Fernández-Del Castillo C; Warshaw AL; Thayer SP; Liss AS
Clin Cancer Res; 2016 Aug; 22(16):4259-70. PubMed ID: 27169995
[TBL] [Abstract][Full Text] [Related]
12. Targeting of the P2X7 receptor in pancreatic cancer and stellate cells.
Giannuzzo A; Saccomano M; Napp J; Ellegaard M; Alves F; Novak I
Int J Cancer; 2016 Dec; 139(11):2540-52. PubMed ID: 27513892
[TBL] [Abstract][Full Text] [Related]
13. hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma.
Lastraioli E; Perrone G; Sette A; Fiore A; Crociani O; Manoli S; D'Amico M; Masselli M; Iorio J; Callea M; Borzomati D; Nappo G; Bartolozzi F; Santini D; Bencini L; Farsi M; Boni L; Di Costanzo F; Schwab A; Onetti Muda A; Coppola R; Arcangeli A
Br J Cancer; 2015 Mar; 112(6):1076-87. PubMed ID: 25719829
[TBL] [Abstract][Full Text] [Related]
14. PEBP4 promoted the growth and migration of cancer cells in pancreatic ductal adenocarcinoma.
Zhang D; Dai Y; Cai Y; Suo T; Liu H; Wang Y; Cheng Z; Liu H
Tumour Biol; 2016 Feb; 37(2):1699-705. PubMed ID: 26311050
[TBL] [Abstract][Full Text] [Related]
15. A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression.
Wang WY; Hsu CC; Wang TY; Li CR; Hou YC; Chu JM; Lee CT; Liu MS; Su JJ; Jian KY; Huang SS; Jiang SS; Shan YS; Lin PW; Shen YY; Lee MT; Chan TS; Chang CC; Chen CH; Chang IS; Lee YL; Chen LT; Tsai KK
Gastroenterology; 2013 Nov; 145(5):1110-20. PubMed ID: 23896173
[TBL] [Abstract][Full Text] [Related]
16. Induction of cell death in pancreatic ductal adenocarcinoma by indirubin 3'-oxime and 5-methoxyindirubin 3'-oxime in vitro and in vivo.
Sano M; Ichimaru Y; Kurita M; Hayashi E; Homma T; Saito H; Masuda S; Nemoto N; Hemmi A; Suzuki T; Miyairi S; Hao H
Cancer Lett; 2017 Jul; 397():72-82. PubMed ID: 28347789
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
[TBL] [Abstract][Full Text] [Related]
18. Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer.
Yamamoto K; Tateishi K; Kudo Y; Hoshikawa M; Tanaka M; Nakatsuka T; Fujiwara H; Miyabayashi K; Takahashi R; Tanaka Y; Ijichi H; Nakai Y; Isayama H; Morishita Y; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M; Koike K
Oncotarget; 2016 Sep; 7(38):61469-61484. PubMed ID: 27528027
[TBL] [Abstract][Full Text] [Related]
19. RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis.
Li X; Xiao Y; Fan S; Xiao M; Wang X; Chen X; Li C; Zong G; Zhou G; Wan C
Exp Mol Pathol; 2016 Oct; 101(2):176-186. PubMed ID: 27498047
[TBL] [Abstract][Full Text] [Related]
20. A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras/Mek/Erk-induced hyperactive mTOR signalling.
Kong B; Wu W; Cheng T; Schlitter AM; Qian C; Bruns P; Jian Z; Jäger C; Regel I; Raulefs S; Behler N; Irmler M; Beckers J; Friess H; Erkan M; Siveke JT; Tannapfel A; Hahn SA; Theis FJ; Esposito I; Kleeff J; Michalski CW
Gut; 2016 Apr; 65(4):647-57. PubMed ID: 25601637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
